GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis

Increasing evidence indicates that obesity is highly associated with chronic kidney disease (CKD). GLP-1 receptor (GLP-1R) agonist has shown benefits on kidney diseases, but its direct role on kidney metabolism in obesity is still not clear. This study aims to investigate the protection and metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chengshi, Li, Ling, Liu, Shuyun, Liao, Guangneng, Li, Lan, Chen, Younan, Cheng, Jingqiu, Lu, Yanrong, Liu, Jingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873987/
https://www.ncbi.nlm.nih.gov/pubmed/29590132
http://dx.doi.org/10.1371/journal.pone.0193473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873987/
https://www.ncbi.nlm.nih.gov/pubmed/29590132
http://dx.doi.org/10.1371/journal.pone.0193473

Ejemplares similares